Navigation Links
Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
Date:6/19/2008

ion for which mucus build up and clearance is a daily problem. Our bronchiectasis program follows closely behind our work in cystic fibrosis where a phase 3 clinical trial is expected to soon close recruitment.''

Pharmaxis is developing Bronchitol as a treatment to improve mucus clearance in the lungs of patients with cystic fibrosis, bronchiectasis and other acute and chronic pulmonary conditions. The U.S. FDA has granted Bronchitol fast track status and it is designated as an orphan drug in the U.S.

Forward-Looking Statements

The statements contained in this media release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this media release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for Aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and we assume no obligation to update any such forward-looking statement as a result of new information, future events or otherwise. We cannot guarantee that any product candidate will receive FDA or other regulatory approval or that we will seek any such approval. Factors that could cause or contribute to such differences include, but are not limited to, factors discussed in the "Risk Factors and Other Uncertainties" section of our Form 20-F lodged with the U.S. Securities and Exchange Commission.

CONTACT:

Alan Robertson

Chief Executive Officer

Tel: +61-2-9454-7200

Email: alan.robertson@pharmaxis.com.au

Released through:

United States:

Brandon Lewis, Trout Group

Tel: +1-646-378-2915

Email: blewis@troutgro
'/>"/>

SOURCE Pharmaxis Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmaxis Establishes Named Patient Program for Bronchitol
2. Pharmaxis Long-Term Safety Study of Bronchitol Completes
3. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
4. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
5. Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women
6. Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations
7. Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System
8. Texas Heart(R) Institute at St. Lukes Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type
9. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
10. Specialized Genasense(R) Clinical Trials Featured at AACR Meeting
11. Associated Foot & Ankle Specialists Enrolling Patients With Chronic Diabetic Foot Ulcers for MATRIX Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... and Development Trend Forecast of Pharmaceutical Equipment Market in ... Research and Development Trend Forecast of Pharmaceutical Equipment ... analyzes China,s pharmaceutical equipment industry ... demand, competition landscape, and business performance of domestic major ...
(Date:8/29/2014)... 2014 According to the ... Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User ... Gene Synthesis, NGS, DNA, RNAi) - Global Forecast ... Synthesis Market is expected to reach $1,712.1 Million ... at a CAGR of 9.8% from 2014 to ...
(Date:8/29/2014)... 2014 /PRNewswire-iReach/ -- ChemImage will present a workshop focused ... Zealand Forensic Science Society,s 22 nd International ... Adelaide, Australia .  Forensic Scientists will be ... hyperspectral imaging can bring to examination procedures. ... of Product Development at ChemImage, will host a ...
Breaking Medicine Technology:Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
(Date:9/1/2014)... Although cannabis commonly known as marijuana ... by Massachusetts General Hospital (MGH) investigators found that ... for substance use disorder reported experiencing symptoms of ... dependence. Study participants reporting withdrawal were more ... and for mood disorders, although the presence or ...
(Date:9/1/2014)... 02, 2014 iFitDress.com, a professional company ... its new selection of modest evening dresses . ... cuts on these great evening gowns. All customers can ... August 16, 2014. , iFitDress.com is one of ... designers and production workers are striving to create more ...
(Date:9/1/2014)... “Australia Hernia Repair Market Outlook to ... Repair market. The report provides value, in millions of ... US dollars) within market segments –, ... ,     Composite Meshes and Biological Meshes. ... the correction of a hernia (a bulging of internal ...
(Date:9/1/2014)... (HealthDay News) -- Having regular family meals may help ... "cyberbullying," a new study suggests. Online abuse can ... experts. "One in five adolescents experience cyberbullying," Frank ... Social Policy at McGill University in Montreal, said in ... media, and online harassment and abuse are difficult for ...
(Date:9/1/2014)... with mental health and substance use problems in ... from the consequences of cyberbullying and also be ... J. Elgar, Ph.D., of McGill University, Montreal, Canada, ... adolescents has experienced recent online bullying and cyberbullying, ... mental health problems in teens as well as ...
Breaking Medicine News(10 mins):Health News:Cannabis withdrawal symptoms common among adolescents treated for substance use disorder 2Health News:Cannabis withdrawal symptoms common among adolescents treated for substance use disorder 3Health News:iFitDress.com: New Modest Evening Wear Selection Now Unveiled Online 2Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 2Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 3Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 4Health News:Family Meals May Defuse Cyberbullying's Impact, Study Says 2Health News:Family dinners good for teens' mental health, could protect from cyberbullying 2Health News:Family dinners good for teens' mental health, could protect from cyberbullying 3
... , LYSOL(R) Helps Protect Families by Killing 99.9% of Illness-Causing Bacteria ... Your family may not be the only ones getting comfy and ... relax and play at home can harbor thousands of bacteria. ... bacteria can live on them for months.(1) , ...
... ... determine the extent of drowsy Truck Drivers, Bus Drivers, Commuter Train Operators, Airline Pilots, ... ... Snoring Isn,t Sexy ® announces the launch of an anonymous, confidential survey to ...
... recipients to suppress their immune systems, has a paradoxical effect ... Vaccine Center have discovered. In experiments conducted in both ... CD8 T cells, which enable the immune system to respond ... encounter. The results were published online ahead of print ...
... Improved care and overall better health are credited with improved ... having a heart attack for the first time are more ... ago, researchers have confirmed. , But now doctors are ... survivable -- what doctors, hospitals and individuals are doing right, ...
... and implantable cardiac devices in Europe was presented on Sunday ... Heart Rhythm Association (EHRA) 1 which takes place in ... and figures, including the current status of healthcare systems across ... . "This document is intended to be the starting ...
... frail elderly and disabled Ohioans , , COLUMBUS, ... Coalition, consisting of the three organizations representing Ohio,s skilled ... frail elderly and disabled Ohioans, today expressed their alarm ... Friday. , , "While we respect the Governor,s ...
Cached Medicine News:Health News:Harmful Bacteria May Hide on Soft Surfaces in Your Home 2Health News:Snoring Isn't Sexy, LLC Launches Survey to Determine Extent of Drowsy Drivers on Land, Sea and In The Air 2Health News:Transplant drug stimulates immune memory 2Health News:Heart Attacks Less Often Fatal Today 2Health News:Heart Attacks Less Often Fatal Today 3Health News:Big disparities in the treatment of arrhythmias across Europe 2Health News:Big disparities in the treatment of arrhythmias across Europe 3Health News:Big disparities in the treatment of arrhythmias across Europe 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: